Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Heartburn efficacy study

This article was originally published in The Tan Sheet

Executive Summary

Out of nearly 2,000 study participants and GERD sufferers in Europe and the U.S., those who took prescribed proton pump inhibitors were more likely to have improved symptoms than those whose symptoms were undiagnosed and took OTC remedies, according to a study presented during Digestive Disease Week May 14-19 in Chicago. Roger Jones, Guy's King's and St. Thomas School of Medicine, et al., used a 100-item questionnaire to identify participants. "Of undiagnosed sufferers taking OTC medicines, 81% still suffered some symptoms compared with 68% of diagnosed patients taking prescription drugs and 69% of diagnosed patients taking PPIs," the study states. Astrazeneca, marketer of prescription Nexium, provided funding for the study...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS098255

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel